PFU
TXG icon

Parus Finance (UK)’s 10x Genomics TXG Stock Holding History

Parus Finance (UK)’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,180
Closed -$237K – 37
2024
Q2 		$237K Buy
12,180
+750
+7% +$19.6K 0.07% 34
2024
Q1 		$429K Sell
11,430
-610
-5% -$26.8K 0.16% 30
2023
Q4 		$674K Sell
12,040
-615
-5% -$26.8K 0.35% 23
2023
Q3 		$522K Sell
12,655
-1,315
-9% -$68.4K 0.33% 22
2023
Q2 		$780K Sell
13,970
-149
-1% -$8.06K 0.32% 23
2023
Q1 		$788K Buy
14,119
+384
+3% +$17.9K 0.47% 23
2022
Q4 		$501K Sell
13,735
-580
-4% -$19K 0.34% 27
2022
Q3 		$408K Buy
14,315
+906
+7% +$34.5K 0.35% 26
2022
Q2 		$607K Sell
13,409
-35
-0.3% -$1.82K 0.36% 27
2022
Q1 		$1.02M Buy
13,444
+6,180
+85% +$541K 0.37% 27
2021
Q4 		$1.08M Buy
+7,264
New +$1.11M 0.35% 30

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Parus Finance (UK)'s TXG Position: Q3 2024 in Review

Parus Finance (UK) sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 12,180 shares — an estimated $237K sold.

Parus Finance (UK) first reported a position in TXG in Q4 2021 and held it in 11 quarters. The position peaked at $1.08M in Q4 2021. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Parus Finance (UK) reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • Parus Finance (UK) sold 12,180 10x Genomics shares in Q3 2024, an estimated $237K.
  • Parus Finance (UK) first reported a position in 10x Genomics in Q4 2021 and held it in 11 quarters.
  • Parus Finance (UK)'s 10x Genomics position peaked at $1.08M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Parus Finance (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.